Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis C (CHC)”

77 trials

Showing 20 of 77 results

Not applicableStudy completedNCT00724464
What this trial is testing

Efficacy of PegIntron (Peginterferon Alfa-2b) and Rebetol (Ribavirin) in Treatment-naïve Subjects With Chronic Hepatitis C in Clinical Practice in Greece (Study P05209)

Who this might be right for
Hepatitis C, ChronicHepatitis C
Merck Sharp & Dohme LLC 332
Not applicableEnded earlyNCT01100749
What this trial is testing

Chronic Hepatitis C (CHC) - Genotype 3 Infection in Canada

Who this might be right for
Chronic Hepatitis C - Genotype 3
University Health Network, Toronto 25
Testing effectiveness (Phase 2)Study completedNCT01710501
What this trial is testing

Different Doses of Grazoprevir (MK-5172) Given With Pegylated Interferon Alfa-2b and Ribavirin to Treatment-Naïve Participants With Chronic Hepatitis C (MK-5172-038)

Who this might be right for
Chronic Hepatitis C (CHC)
Merck Sharp & Dohme LLC 87
Very early researchStudy completedNCT03188276
What this trial is testing

The Relationship Between MDSCs and NK Cells Activity of CHC Patient Treated by DAAs

Who this might be right for
Chronic Hepatitis C
Third Affiliated Hospital, Sun Yat-Sen University 52
Testing effectiveness (Phase 2)Study completedNCT00377182
What this trial is testing

Hepatitis C Virus (HCV) Polymerase Inhibitor Pro-Drug in Combination With PEGASYS With or Without COPEGUS in Patients With Chronic Hepatitis C (CHC) Genotype 1 Infection.

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 107
Not applicableUnknownNCT04405011
What this trial is testing

NUC in Preventing HBV Reactivation in HCV/HBV Co-infected Patients Receiving DAA for CHC

Who this might be right for
HBV/HCV Co-infection
National Taiwan University Hospital 60
Not applicableStudy completedNCT01850745
What this trial is testing

Multidisciplinary Support Program in Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Parc de Salut Mar 447
Post-approval studies (Phase 4)Study completedNCT00686777
What this trial is testing

Pegylated Interferon (PEG-IFN) Alfa-2b and Low Dose Ribavirin for the Treatment of Chronic Hepatitis C Patients With Genotype 1 High Viral Load and Low Body Weight (Study P05172)(COMPLETED)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 75
Large-scale testing (Phase 3)Ended earlyNCT02791256
What this trial is testing

Peginterferon Alfa-2a Plus Ribavirin in Early Non-Responder Participants With Chronic Hepatitis C (CHC) Genotype 1, 4, 5, and 6

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 23
Post-approval studies (Phase 4)Study completedNCT01258101
What this trial is testing

PEGASYS (Peginterferon Alfa-2a) Plus Ribavirin in Patients With Chronic Hepatitis C (CHC), Genotype 2 or 3

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 395
Not applicableStudy completedNCT02508090
What this trial is testing

Long-Term Extension Study of Miravirsen Among Participants With Genotype 1 Chronic Hepatitis C (CHC) Who Have Not Responded to Pegylated-Interferon Alpha Plus Ribavirin

Who this might be right for
Chronic Hepatitis C
Hoffmann-La Roche 10
Post-approval studies (Phase 4)Study completedNCT00077636
What this trial is testing

ACCELERATE Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC) Infection.

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 1,469
Post-approval studies (Phase 4)UnknownNCT01056172
What this trial is testing

PegIFN Alfa-2a and RBV for 16 or 24 Weeks in Patients With Chronic Hepatitis C(CHC) 2 With Rapid Virologic Response(RVR)

Who this might be right for
Chronic Hepatitis C
Pusan National University Yangsan Hospital 164
Large-scale testing (Phase 3)Study completedNCT02806505
What this trial is testing

HELPS Study - A Study of Peginterferon Alfa-2a (Pegasys) in Patients With Chronic Hepatitis C (CHC) and End-Stage Renal Disease (ESRD)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 81
Post-approval studies (Phase 4)Study completedNCT00412334
What this trial is testing

SYREN Study: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Copegus (Ribavirin) in Non-Responder Patients With Chronic Hepatitis C (CHC) Genotype 1.

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 104
Post-approval studies (Phase 4)Study completedNCT03144635
What this trial is testing

G1b CHC Patients With CKD-3 Treated With Grazoprevir Plus Elbasvir

Who this might be right for
Hepatitis C ViralChronic Kidney Disease stage3
Kyushu University 80
Testing effectiveness (Phase 2)Study completedNCT02583685
What this trial is testing

Switching Regimen in Treating Cirrhotic HCV GT1b Subjects

Who this might be right for
Chronic Hepatitis C Infection
Humanity and Health Research Centre 138
Large-scale testing (Phase 3)Study completedNCT00304551
What this trial is testing

Peginterferon Alfa-2a in Combination With Ribavirin in Chronic Hepatitis C (CHC) Patients With Compensated Liver Cirrhosis (LC)

Who this might be right for
Liver CirrhosisChronic Hepatitis C
Chugai Pharmaceutical 180
Not applicableStudy completedNCT03868163
What this trial is testing

Real World Evidence of the Effectiveness and Clinical Practice Use of Glecaprevir Plus Pibrentasvir in Patients With Chronic Hepatitis C in the Russian Federation

Who this might be right for
Chronic Hepatitis C (CHC)
AbbVie 161
Not applicableEnded earlyNCT03500562
What this trial is testing

Study of Daclatasvir-based Therapy in Chinese Participants With Chronic Hepatitis C (CHC)

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 3
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation